[1]
Selvan, K.C. et al. 2025. Oral Pulmonary Arterial Hypertension-Targeted Therapy in Patients With Pulmonary Hypertension due to Interstitial Lung Disease. Journal of Clinical Medicine Research. 17, 3 (Mar. 2025), 153–163. DOI:https://doi.org/10.14740/jocmr6164.